APA (7th ed.) Citation

S, M., R, J., M, S., LG, F., G, S., B, W., . . . AK, B. (2024). Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: A retrospective cohort study. The Lancet. Oncology, 25(12), 1666. https://doi.org/10.1016/S1470-2045(24)00528-X

Chicago Style (17th ed.) Citation

S, Miller, et al. "Effectiveness and Safety of Immune Checkpoint Inhibitors in Black Patients Versus White Patients in a US National Health System: A Retrospective Cohort Study." The Lancet. Oncology 25, no. 12 (2024): 1666. https://doi.org/10.1016/S1470-2045(24)00528-X.

MLA (9th ed.) Citation

S, Miller, et al. "Effectiveness and Safety of Immune Checkpoint Inhibitors in Black Patients Versus White Patients in a US National Health System: A Retrospective Cohort Study." The Lancet. Oncology, vol. 25, no. 12, 2024, p. 1666, https://doi.org/10.1016/S1470-2045(24)00528-X.